Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -3.10 | $0 | -$531,640 |
| 2026 Q1 | -4.30 | $0 | -$2M |
| 2025 Q4 | -12.90 | $0 | -$973,012 |
| 2025 Q3 | -10.50 | $0 | -$3M |
| 2025 Q2 | -32.90 | $0 | -$3M |
| 2025 Q1 | -7.50 | $0 | -$3M |
| 2024 Q4 |
| -5.40 |
| $0 |
| -$3M |
| 2024 Q3 | -3.70 | $0 | -$2M |